BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31015121)

  • 1. Differential inflammatory response dynamics in normal lung following stereotactic body radiation therapy with protons versus photons.
    Li Y; Dykstra M; Best TD; Pursley J; Chopra N; Keane FK; Khandekar MJ; Sharp GC; Paganetti H; Willers H; Fintelmann FJ; Grassberger C
    Radiother Oncol; 2019 Jul; 136():169-175. PubMed ID: 31015121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
    Seco J; Panahandeh HR; Westover K; Adams J; Willers H
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic Late-phase Radiographic Changes Among Chest-Wall Patients Are Associated With a Proton RBE Exceeding 1.1.
    Underwood TSA; Grassberger C; Bass R; MacDonald SM; Meyersohn NM; Yeap BY; Jimenez RB; Paganetti H
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):809-819. PubMed ID: 29976493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
    Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and radiation induced lung injury after thoracic stereotactic body radiotherapy.
    Kalman NS; Hugo GD; Mahon RN; Deng X; Mukhopadhyay ND; Weiss E
    Radiother Oncol; 2018 Nov; 129(2):270-276. PubMed ID: 30253874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?
    Tang X; Shen Y; Meng Y; Hou L; Zhou C; Yu C; Jia H; Wang W; Ren G; Cai J; Li XA; Yang H; Kong FS
    Ann Palliat Med; 2021 Mar; 10(3):2832-2842. PubMed ID: 33548998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
    Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
    Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Prasanna PG; Rawojc K; Guha C; Buchsbaum JC; Miszczyk JU; Coleman CN
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1325-1340. PubMed ID: 33640423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated robust SBPT planning using EUD-based prediction of SBRT plan for patients with lung cancer.
    Wei L; Wang W; Dai Z; Li Y; Shang H
    Comput Methods Programs Biomed; 2021 Sep; 209():106338. PubMed ID: 34390935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.
    Palma DA; van Sörnsen de Koste J; Verbakel WF; Vincent A; Senan S
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):974-8. PubMed ID: 20932655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
    Ma SJ; Serra LM; Syed YA; Hermann GM; Gomez-Suescun JA; Singh AK
    Clin Lung Cancer; 2018 Mar; 19(2):e235-e240. PubMed ID: 29153897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.
    Rice SR; Saboury B; Houshmand S; Salavati A; Kalbasi A; Goodman CR; Werner TJ; Vujaskovic Z; Simone CB; Alavi A
    Nucl Med Commun; 2019 Jun; 40(6):618-625. PubMed ID: 31095527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
    Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
    J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New System.
    Raziee H; Hope A; Faruqi S; Yap ML; Roberts H; Kandel S; Le LW; Brade A; Cho J; Sun A; Bezjak A; Giuliani ME
    Clin Lung Cancer; 2015 Nov; 16(6):e245-51. PubMed ID: 26077096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-small-cell Lung Cancer: A Two-institution Propensity-matched Analysis.
    Cummings MA; Ma SJ; Hermann G; Serra L; Syed Y; Malhotra HK; Chen Y; Milano MT; Gomez-Suescun JA; Singh DP; Singh AK
    Clin Lung Cancer; 2018 Nov; 19(6):511-517. PubMed ID: 30131257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
    Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
    Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.